Type of security: Stock
Sector: Health Care
Industry: Major Pharmaceuticals
The data is delayed by 15 minutes.
AMPH is in the medium-term up 25% in 1 year.
Description: Amphastar Pharmaceuticals, Inc., a generic and specialty pharmaceutical company, engages in the discovery, development, manufacture, and marketing of generic and proprietary pharmaceuticals, delivery systems, and active pharmaceutical ingredients. The company focuses on injectable, inhalation, and other categories of pharmaceutical products. Its products include Enoxaparin Sodium Injection, which is indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism and the inpatient/outpatient treatment of acute deep vein thrombosis; Amphadase, a protein enzyme that is prepared from a highly purified bovine testicular hyaluronidase; Cortrosyn for Injection, a diagnostic agent that is used in the screening of patients presumed to have adrenocortocal insufficiency; and prefilled disposable emergency syringes for crash cart use. The company?s products also include Lidocaine HCl Jelly, a preservative-free topical local anesthetic agent that is provided in a prefilled syringe; Naloxone HCl
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||EPS||0.15||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||16.09%||Sales Growth - Q/Q||1.81%||P/E||110.8|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||-2.46%||ROE||-3.49%||ROI||-3.08%|
|Current Ratio||2.81||Quick Ratio||1.63||Long Term Debt/Equity||0.27||Debt Ratio||0.26|
|Gross Margin||23.49%||Operating Margin||-10.51%||Net Profit Margin||-4.4%||Dividend Payout Ratio|
|Cash From Financing Activities||4.45 M||Cash From Investing Activities||-5.04 M||Cash From Operating Activities||1.34 M||Gross Profit||13.28 M|
|Net Profit||-670 K||Operating Profit||-7.26 M||Total Assets||396.5 M||Total Current Assets||202.6 M|
|Total Current Liabilities||72.09 M||Total Debt||48.42 M||Total Liabilities||117.22 M||Total Revenue||56.89 M|
|High 52 week||25.28||Low 52 week||14.63||Last close||20.16||Last change||1.2%|
|RSI||46.53||Average true range||0.55||Beta||0.91||Volume||248.19 K|
|Simple moving average 20 days||-2.85%||Simple moving average 50 days||-9.46%||Simple moving average 200 days||0.59%|
|Performance Week||-3.86%||Performance Month||-3.72%||Performance Quart||-8.7%||Performance Half||8.21%|
|Performance Year||3.07%||Performance Year-to-date||1.31%||Volatility daily||1.54%||Volatility weekly||3.44%|
|Volatility monthly||7.06%||Volatility yearly||24.45%||Relative Volume||233.02%||Average Volume||192.15 K|
|New High||New Low|
2019-04-15 09:30:00 | Small Cap Pot Stocks Can Bring Investors High Profits-THC Therapeutics, Inc.
2019-04-10 09:30:01 | MNK vs. AMPH: Which Stock Is the Better Value Option?
2019-03-26 17:32:59 | Amid talk of buyout, Peninsula biotech zeroes in on its blood-thinner antidote
2019-03-25 09:30:01 | MNK vs. AMPH: Which Stock Should Value Investors Buy Now?
2019-03-13 16:17:11 | This Biotech Sees Markets Worth Billions — But Can It Survive A 'Pause'?
2019-03-13 10:24:20 | Does Market Volatility Impact Amphastar Pharmaceuticals, Inc.’s NASDAQ:AMPH Share Price?
2019-03-13 09:24:10 | Edited Transcript of AMPH earnings conference call or presentation 12-Mar-19 9:00pm GMT
2019-03-13 02:36:44 | Amphastar Pharmaceuticals AMPH Q4 2018 Earnings Conference Call Transcript
2019-03-12 19:10:11 | Amphastar Pharmaceuticals AMPH Beats Q4 Earnings and Revenue Estimates
2019-03-12 18:16:14 | Amphastar: 4Q Earnings Snapshot
2019-03-12 15:00:00 | Amphastar Pharmaceuticals Inc to Host Earnings Call
2019-03-12 07:31:32 | Amphastar Pharmaceutical Q4 Earnings Preview
2019-03-08 09:30:02 | MNK vs. AMPH: Which Stock Should Value Investors Buy Now?
2019-02-26 08:15:00 | Market Trends Toward New Normal in Micron Technology, Harris, Sientra, Noble, Amphastar Pharmaceuticals, and CECO Environmental — Emerging Consolidated Expectations, Analyst Ratings
2019-02-13 09:30:02 | MNK vs. AMPH: Which Stock Should Value Investors Buy Now?
2019-01-29 13:38:39 | Who Has Been Selling Amphastar Pharmaceuticals, Inc. NASDAQ:AMPH Shares?
2019-01-28 09:30:02 | MNK vs. AMPH: Which Stock Should Value Investors Buy Now?
2019-01-11 09:30:02 | MNK vs. AMPH: Which Stock Should Value Investors Buy Now?
2018-12-25 09:30:02 | BHC vs. AMPH: Which Stock Is the Better Value Option?
2018-12-23 21:20:33 | Is Amphastar Pharmaceuticals Inc AMPH A Good Stock To Buy?
2018-12-21 11:04:50 | How Much Did Amphastar Pharmaceuticals, Inc.’s NASDAQ:AMPH CEO Pocket Last Year?
2018-12-03 08:52:01 | Amphastar Pharmaceuticals AMPH Catches Eye: Stock Jumps 6.7%
2018-11-27 08:45:00 | New Research Coverage Highlights Phibro Animal Health, RadNet, Amphastar Pharmaceuticals, FibroGen, Sientra, and Flexion Therapeutics — Consolidated Revenues, Company Growth, and Expectations for 2018
2018-11-22 09:30:02 | BHC or AMPH: Which Is the Better Value Stock Right Now?
2018-11-21 10:42:17 | What You Must Know About Amphastar Pharmaceuticals Inc’s NASDAQ:AMPH Financial Strength
2018-11-09 06:00:00 | Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference 2018
2018-11-08 21:37:03 | Edited Transcript of AMPH earnings conference call or presentation 8-Nov-18 10:00pm GMT
2018-11-08 21:32:22 | Amphastar Pharmaceuticals Inc AMPH Q3 2018 Earnings Conference Call Transcript
2018-11-08 20:40:01 | Amphastar Pharmaceuticals AMPH Matches Q3 Earnings Estimates
2018-11-08 19:33:25 | Amphastar: 3Q Earnings Snapshot
2018-11-07 21:55:38 | Amphastar Pharmaceuticals, Inc. Announces Reintroduction of Primatene® MIST
2018-11-06 09:30:02 | MNK or AMPH: Which Is the Better Value Stock Right Now?
2018-10-16 09:15:00 | Consolidated Research: 2018 Summary Expectations for Freightcar America, Star Bulk Carriers, Avis Budget Group, Adamas Pharmaceuticals, Model N, and Amphastar Pharmaceuticals — Fundamental Analysis, Key Performance Indications
2018-10-12 10:18:11 | Who Are The Major Shareholders In Amphastar Pharmaceuticals Inc NASDAQ:AMPH?
2018-10-02 09:30:01 | MNK or AMPH: Which Is the Better Value Stock Right Now?
2018-09-13 09:30:01 | AKRX vs. AMPH: Which Stock Should Value Investors Buy Now?
2018-08-29 16:05:00 | Amphastar Pharmaceuticals to Present at the Wells Fargo Healthcare Conference 2018
2018-08-27 09:30:01 | AKRX vs. AMPH: Which Stock Should Value Investors Buy Now?
2018-08-22 15:40:10 | Edited Transcript of AMPH earnings conference call or presentation 8-Aug-18 9:00pm GMT
2018-08-20 08:00:00 | Investor Expectations to Drive Momentum within Rapid7, 1-800 FLOWERS.COM, SMART Global, Prothena Corporation plc, Amphastar Pharmaceuticals, and Silvercorp Metals — Discovering Underlying Factors of Influence